Abbott Laboratories (ABT)
Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
Recs
TrackMyself
(25.23)
Submitted: 10/21/2009 9:08:34 PM :
Start Price:
$51.12
ABT Score:
+1.78
Tracking some of my real portfolio
Recs
Blygh
(< 20)
Submitted: 10/19/2009 4:34:26 PM :
Start Price:
$51.98
ABT Score:
+1.70
Solid company - health care has under performed S&P 500 - improving earnings
Recs
grmind
(71.63)
Submitted: 10/16/2009 8:19:01 PM :
Start Price:
$51.46
ABT Score:
+1.91
Best of big pharma
Recs
deadrock
(30.81)
Submitted: 10/16/2009 11:42:20 AM :
Start Price:
$51.59
ABT Score:
+1.10
well run company with a relatively safe dividend
Recs
SWEAT7
(< 20)
Submitted: 10/12/2009 11:08:52 PM :
Start Price:
$49.77
ABT Score:
+3.78
Abbott has been in a large growth slow movement pattern for a significant timeframe. after earning, expect ABT to break resistance for a 4 to 5 % tick up.
Recs
LadyLeapTrader
(48.54)
Submitted: 10/4/2009 7:44:47 PM :
Start Price:
$49.41
ABT Score:
+0.22
Money is going into this stock, breakout above W pattern.
Recs
pharmdoc13
(63.21)
Submitted: 10/1/2009 8:18:24 PM :
Start Price:
$48.02
ABT Score:
+2.29
Obamacare is scary but infections are getting worse. Abbott is the best antimicrobial maker period.
Recs
SierraBlue
(< 20)
Submitted: 9/30/2009 10:41:56 PM :
Start Price:
$48.88
ABT Score:
+3.73
Telechart Scans
Recs
OutofDate1980
(< 20)
Submitted: 9/23/2009 10:34:37 PM :
Start Price:
$45.71
ABT Score:
+12.25
Value catch-up.
Recs
TMFmrquakeroats
(86.73)
Submitted: 9/17/2009 10:07:48 AM :
Start Price:
$46.53
ABT Score:
+10.86
Quality stalwart. Pays a nice dividend and is rated 5 stars by the best CAPS players.
Recs
A00971591
(27.93)
Submitted: 9/10/2009 6:28:00 PM :
Start Price:
$46.52
ABT Score:
+8.25
Good strong company that is diversified well, the four segments of this company seem to be very promising. Let's just hope Obama care doesn't make this company tank
Recs
dhloucks
(77.90)
Submitted: 9/5/2009 10:22:51 AM :
Start Price:
$45.31
ABT Score:
+9.24
Good vaue stock and yield. Like chart.
Recs
richardrogers4
(65.06)
Submitted: 9/4/2009 2:54:51 AM :
Start Price:
$44.79
ABT Score:
+8.32
Defensive pick
Recs
Recs
BigFatBEAR
(99.30)
Submitted: 8/21/2009 12:32:48 PM :
Start Price:
$45.25
ABT Score:
+9.08
Hugely stable and mature, I believe this low-beta slow-grower is undervalued relative to the pricey market.
Recs
mrindependent
(98.79)
Submitted: 8/21/2009 10:00:34 AM :
Start Price:
$45.42
ABT Score:
+8.57
Abbott Laboratories is a good play on the concept that the health care reforms will not be as devastating as feared for health care providers. At its current price, Abbott Labs looks cheap based on both its P/E (13 vs typical historical p/e's in the twenties) and price/book value (3.8 versus typical p/bv's in the 5 to 7 range). Company is widely diversified across pharmaceuticals, diagnositics, nutritional and vascular. StockScouter rating is 9.
Recs
agstocknut
(25.79)
Submitted: 8/19/2009 9:52:05 AM :
Start Price:
$43.83
ABT Score:
+8.78
Earnings just keep growing!
Recs
stockintrade
(88.85)
Submitted: 8/14/2009 5:14:36 PM :
Start Price:
$43.65
ABT Score:
+9.16
Rock steady, dividend history, reasonably well managed, well-diversified in terms of product, markets and geographies. Plus, it's PE of 12.93, EPS (ttm) of 3.43, and Div & Yield of 1.60 (3.60%) is not easiy matched. Hello???
Recs
intlvaw
(91.65)
Submitted: 8/3/2009 10:30:43 AM :
Start Price:
$44.02
ABT Score:
+9.19
Excellent pipeline, nutriional business to balance - capable of cutting R&D to reflect any US health care policies that emerge -- Cheap
Recs
sandrick
(90.76)
Submitted: 8/1/2009 12:11:12 AM :
Start Price:
$44.72
ABT Score:
-7.45
legal & contractual issues
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 212 1 2 3 4 5 6 7 8 9 10 Next »